Pan-tranquil
Brand names,
Pan-tranquil
Analogs
Pan-tranquil
Brand Names Mixture
Pan-tranquil
Chemical_Formula
C20H23NS
Pan-tranquil
RX_link
No information avaliable
Pan-tranquil
fda sheet
Pan-tranquil
msds (material safety sheet)
Pan-tranquil
Synthesis Reference
No information avaliable
Pan-tranquil
Molecular Weight
309.469 g/mol
Pan-tranquil
Melting Point
< 25 oC
Pan-tranquil
H2O Solubility
Soluble as HCl salt
Pan-tranquil
State
Liquid
Pan-tranquil
LogP
5.7
Pan-tranquil
Dosage Forms
Tablets (oral, 1 mg)
Pan-tranquil
Indication
Used for the symptomatic treatment of parkinsonism.
Pan-tranquil
Pharmacology
Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.
Pan-tranquil
Absorption
Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.
Pan-tranquil
side effects and Toxicity
Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.
Pan-tranquil
Patient Information
Pan-tranquil
Organisms Affected
Humans and other mammals